Foundation / Corporation
Leukemia Research Foundation
03/18/19 11:59 PM EST
Grants to USA, Canada, and International emerging investigators for blood cancer research. Preference will be given to projects that focus on lymphoma, leukemia, multiple myeloma, and MDS. Applicants must submit a letter of intent prior to submitting a full application.
Funding is intended for individuals that are in the process of establishing their own laboratories and are no longer under the tutelage of a senior scientist mentor. These one year grants are $100,000 each, an impressive amount that allows innovative scientists to act on their ideas, and try new procedures and experiments that will lead to significant breakthroughs. The Leukemia Research Foundation currently funds New Investigator grants only.
GrantWatch ID#: 168590
The amount is up to $100,000.
The grant period is one year, from July 1, 2019 – June 30, 2020.
- New Investigators are considered to be within seven (7) years of their first independent position as of July 1, 2020. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years. Questions regarding eligibility should be directed to our Research Grants Administrator.
- Adjustments for career interruptions can be made. These could include but are not limited to, family leave, military service, major illness or injury. It is the responsibility of the applicant to point out and document such interruptions.
- Investigators at the instructor level or similar position must include a letter from the department chair confirming their independence. The letter should also describe the facilities and resources available to the applicant.
- Applicants with an NIH KO8 or K23 are eligible.
- Applicants are not required to be U.S. citizens.
- Research projects undertaken outside the U.S. will be considered.
- DOE, DOD, NSF, R21, or other grants with less than $175,000 per year in total direct costs are permitted. (Multiple grants which, when added together, have a total of $175,000 or more per year in total direct costs are excluded.)
- NIH RO1 funding, VA Merit Award or equivalent.
- Career development awards from other national foundations, (ACS, ASH, Burroughs Wellcome, Kimmel Scholar, etc.).
- Any single grant of $175,000 or greater in total direct costs per year.
- Renewal applications will not be accepted.
- The Leukemia Research Foundation's policy does not provide funds for capital equipment (i.e. equipment purchases in excess of $5,000). Any request for exception to this policy must detail clearly the specific need of the capital equipment for the proposed research project.
- The Leukemia Research Foundation does not provide salary support for the principal investigator.
- Using funds for research travel is permitted but should not exceed $1,000. This money is intended only to enhance the study.
- All other support for the project must be clearly detailed including all sources for the requested and related projects. Clearly indicate funding overlap.
- All previous support from the Leukemia Research Foundation must be clearly stated; please list the title of the project, period(s) of support, and amount of award.
- The LRF does not provide indirect cost recovery or institutional overhead costs.
The Leukemia Research Foundation has implemented a 2-step application process:
1. LOI - Letter of Intent - Due February 1, 2019
- A Letter of Inquiry allows the Leukemia Research Foundation to quickly assess if there is a good match between LRF's goals and the project. If it appears to be a good match, the Foundation will request a full proposal.
2. Notification sent for Request for Full Proposal - February 15, 2019
If you are notified and invited to submit a full proposal, the full application will be due March 18, 2019.
Grants will only be accepted electronically; hard copies of grant applications will not be accepted.
All completed applications for the 2019-2020 funding cycle will be reviewed by the Leukemia Research Foundation's independent Medical Advisory Board in early June. The Foundation approves applications for funding based on the recommendation of this panel. Notification will be e-mailed to applicants by June 30, 2019.
About the Foundation:
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
Applications should be e-mailed to: Grants@LRFMail.org.
Questions should be directed to:
Linda Kabot, Director of Programs/Research Grants Administrator
191 Waukegan Road, Ste 105
Northfield, IL 60093
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
USA Territories: American Samoa (USA) Guam (USA) Puerto Rico (USA) Virgin Islands (USA) Northern Mariana Islands (USA)
USA Compact Free Associations: The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA)
Canada: Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon
International country outside of the USA, Israel and Canada.